ReviewMolecular medicine reports2026
Mechanisms of the interaction between aging of the male reproductive system and obesity, and clinical management strategies (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the intensification of the aging of the global population, reproductive health problems among middle‑aged and elderly males have emerged as a prominent public health issue. Late‑onset hypogonadism (LOH), primarily induced by an age‑related gradual reduction in serum testosterone, has garnered widespread clinical attention. The present review systematically elaborates the molecular and cellular mechanisms underlying testicular aging. Specifically, age‑dependent alterations in Sertoli cells, interstitial cells and spermatogonial stem cells, as well as an imbalance in the testicular immune microenvironment, constitute the inherent pathological basis of testicular functional deterioration. A vicious cycle exists between obesity and testosterone deficiency: Obesity‑triggered insulin resistance, chronic low‑grade inflammation and oxidative stress directly inhibit testosterone synthesis and accelerate testicular aging; in turn, low testosterone levels promote visceral fat accumulation and insulin resistance, exacerbating obesity and metabolic disorders. Aging, obesity and testosterone deficiency synergistically drive the pathological progression of LOH. In terms of clinical intervention, the present review classifies the therapeutic strategies for testicular dysfunction induced by genetic, developmental and metabolic disorders based on etiological characteristics. The review also summarizes innovative therapeutic approaches targeting the testicular microenvironment and cellular senescence pathways, as well as frontier research hotspots, including natural product interventions and regenerative medicine. By integrating the interactive mechanisms of testicular aging and obesity and summarizing relevant multidimensional intervention strategies, this review provides a systematic theoretical basis for further exploring the pathogenesis and improving the clinical prevention and treatment system of LOH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.